72989-13-0 Usage
Uses
Used in Psychopharmacology Research:
(12-methoxyibogamin-18-yl)methyl 3,4-dimethoxybenzoate is used as a research compound for its potential therapeutic use in treating addiction and mental health disorders. Its enhanced bioavailability and pharmacological properties, due to the addition of the 3,4-dimethoxybenzoate group, make it a promising candidate for further investigation in this field.
Used in Drug Development:
(12-methoxyibogamin-18-yl)methyl 3,4-dimethoxybenzoate is used as a potential drug candidate for the development of new treatments for addiction and mental health disorders. Its unique properties and the possibility of improved bioavailability and efficacy compared to ibogaine alone make it an interesting compound for pharmaceutical research and development.
Note: Due to the potent psychoactive effects of (12-methoxyibogamin-18-yl)methyl 3,4-dimethoxybenzoate, it should be used with caution and under the guidance of a qualified medical professional.
Check Digit Verification of cas no
The CAS Registry Mumber 72989-13-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,9,8 and 9 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 72989-13:
(7*7)+(6*2)+(5*9)+(4*8)+(3*9)+(2*1)+(1*3)=170
170 % 10 = 0
So 72989-13-0 is a valid CAS Registry Number.
72989-13-0Relevant academic research and scientific papers
Cytotoxicity of modified indole alkaloids
Kingston,Sami
, p. 1403 - 1405 (2007/10/09)
Indole alkaloids of the iboga series were structurally modified by incorporation of a 3,4-dimethoxybenzyl or -benzoyl unit so that they contained the N-O-O triangle required for antileukemic activity according to the triangulation hypothesis. The cytotoxicities of the modified alkaloids in the in vitro P-388 system were not significantly increased over the unmodified alkaloids, suggesting that the triangulation hypothesis does not apply in this series at least.
